Most guidelines still treat indeterminate (Rx) surgical margins after nephrectomy for renal cell carcinoma (RCC) as equivalent to negative (R0) margins, but it is not.

Nephron-sparing surgery may not reduce the risk for later kidney failure in patients with kidney cancer and stage 4 CKD. Despite the promise of nephron-sparing, new study findings suggest that the ...

Feb. 19, 2004 — Adjuvant treatment with autologous renal tumor cell vaccine seems to be beneficial in patients with organ-confined renal cell carcinoma, according to the results of a phase III, ...

Implications of ethnicity among patients with metastatic renal cell carcinoma (mRCC) treated with nivolumab plus ipilimumab (nivo/ipi). This is an ASCO Meeting Abstract from the 2023 ASCO ...

Stage 2 clear cell renal cell carcinoma is typically curable, especially when detected early. Surgery remains the cornerstone of treatment, with excellent outcomes in many cases. Patients are ...

Impact of Comprehensive Genome Profiling on the Management of Advanced Non–Small Cell Lung Cancer: Preliminary Results From the Lung Cancer Cohort of the FPG500 Program Consecutive patients who ...

Please provide your email address to receive an email when new articles are posted on . NASHVILLE, Tenn. — A fully automated artificial intelligence approach predicted post-nephrectomy glomerular ...

Resistance to chemotherapy is typically associated with poor outcomes for patients with cancer. However, St. Jude Children's Research Hospital scientists demonstrated that in bilateral Wilms tumor ...

“The findings of this study provide valuable information for surgical decision-making in patients with localized RCC.” “While both RN and PN demonstrated equivalent and effective cancer control, ...

The probability of surgical success with telesurgery for radical prostatectomy and partial nephrectomy for small renal masses was non-inferior to local robotic surgery in a small randomized trial. The ...